N-Fmoc-D-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid is a protected amino acid derivative featuring a rigid, tricyclic beta-carboline scaffold. The D-configuration at the 3-position and the presence of the Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the secondary amine are key structural characteristics. This compound is a non-proteinogenic, conformationally constrained building block. Its primary application is in the field of peptide and peptidomimetic chemistry, particularly in solid-phase peptide synthesis (SPPS). The beta-carboline core is a privileged structure in medicinal chemistry, known to interact with various biological targets such as serotonin receptors, benzodiazepine receptors, and monoamine oxidases. Incorporating this scaffold into peptides via this Fmoc-protected derivative allows researchers to design and synthesize novel peptide-based drug candidates with enhanced metabolic stability, receptor selectivity, and bioavailability. It is used to create peptidomimetics for potential therapeutic applications in neurological disorders and oncology. The compound is typically handled as a fine chemical reagent under controlled conditions. It requires storage at low temperatures (e.g., -20°C) and protection from light and moisture to maintain stability. It is commercially supplied for research and development purposes in pharmaceutical discovery.